• About
  • Services
  • Clients
  • Client News
  • PCG Research
  • PCG Digital
  • Contact
  • follow:

  • 4 Jan

    LiveXLive Expands Previously Announced Review Of Strategic Opportunities And Alternatives With Assistance of J.P. Morgan

    #LIVX #Stock #invest #livestream #videoondemand

    LOS ANGELES, Jan. 4, 2021 /PRNewswire/ -- LiveXLive Media (Nasdaq: LIVX) ("LiveXLive"), a global platform for livestream and on-demand audio, video and podcast content in music, comedy and pop culture, and owner of PodcastOne, Slacker Radio, React Presents and Custom Personalization Solutions ("CPS"), announced today that it has expanded its recently announced review of strategic opportunities to grow… Read More..

    Share this:
  • 4 Jan

    Hoth Therapeutics Announces Licensing Agreement and Collaboration with U.S. Army Medical Research and Development Command (USAMRDC) for Treating Multi-Drug Resistant Bacterial Lung Infections

    #HOTH #investors #stockmarket #biopharma

    License Covers Novel Molecular Entity Developed by the Walter Reed Army Institute of Research The HT-006 active pharmaceutical ingredient is expected to be a broad-spectrum antibiotic for treatment of serious bacterial infections of the lung NEW YORK, Jan. 4, 2021 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company,… Read More..

    Share this:
  • 4 Jan

    Nephros Provides Year-End Technology Update, Including HDF Program Status

    #NEPH #waterpurification #pathogen #investment

    HDF Assist Device Complete; Special 510(k) to be Filed in Early 2021 Nephros Granted Patent Covering Technology in HDF Assist Module Nephros Expands EndoPur® and S100 Filter Labels to Include Heat Disinfection SOUTH ORANGE, NJ, Jan. 04, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nephros, Inc. (Nasdaq: NEPH), a commercial-stage… Read More..

    Share this:
« Previous 1 … 119 120 121 122 123 … 295 Next »
  • Twitter feed is not available at the moment.
  • QUICK LINKS

    • About
    • Services
    • Clients
    • Client Media
    • PCG Media
    • PCG Research
    • Contact
    • Privacy Policy
    • Disclosures

    FOLLOW US

    Copyright © 2022 PCG Advisory.

    MENU logo
    • About
    • Services
    • Clients
    • Client News
    • PCG Research
    • PCG Digital
    • Contact